ArticleJournal of medicinal chemistry2023

Development of N-Terminally Modified Variants of the CXCR4-Antagonistic Peptide EPI-X4 for Enhanced Plasma Stability.

Mirja Harms et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.